Marex Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
2,408
+1,125
+88% +$611K 0.01% 412
2025
Q4
$743K Sell
1,283
-80,147
-98% -$45.3M ﹤0.01% 458
2025
Q3
$39.5M Sell
81,430
-19,006
-19% -$8.85M 0.28% 73
2025
Q2
$40.7M Sell
100,436
-21,418
-18% -$8.96M 0.35% 66
2025
Q1
$60.6M Buy
121,854
+914
+0.8% +$495K 1.16% 23
2024
Q4
$62.9M Buy
120,940
+916
+0.8% +$504K 1.07% 21
2024
Q3
$74.2M Buy
120,024
+8
+0% +$4.74K 1.69% 16
2024
Q2
$66.4M Sell
120,016
-2,484
-2% -$1.42M 1.78% 10
2024
Q1
$71.2M Buy
+122,500
New +$68.7M 2.31% 9
2023
Q1
Sell
-10,137
Closed -$5.65M 328
2022
Q4
$5.65M Buy
+10,137
New +$5.37M 0.8% 23

Other funds holding TMO

Marex Group's TMO Position: Q1 2026 in Review

Marex Group increased its Thermo Fisher Scientific (TMO) stake by 88% in Q1 2026, buying an estimated $611K and bringing the position to 2,408 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #412.

Marex Group first reported a position in TMO in Q4 2022 and has held it in 10 quarters since. The position peaked at $74.2M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Marex Group held 2,408 shares of Thermo Fisher Scientific worth $1.18M as of Q1 2026.
  • Marex Group bought 1,125 Thermo Fisher Scientific shares in Q1 2026, an estimated $611K.
  • Thermo Fisher Scientific made up 0.01% of Marex Group's portfolio in Q1 2026, its #412 holding.
  • Marex Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 10 quarters since.
  • Marex Group's Thermo Fisher Scientific position peaked at $74.2M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.